Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    Results have been posted on 2025-10-29, including the Best Objective Response Rate (CR + PR) per RECIST 1.1 and the associated results submission dates. The Study Protocol and Statistical Analysis Plan PDF (dated 2024-07-22) was added to Study Documents.
    Difference
    1%
    Check dated 2025-11-04T11:56:00.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    Two screenshots show the same study page with no significant changes to core content (eligibility, interventions, outcomes, or locations); any differences are limited to formatting and date updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:14:01.000Z thumbnail image
  3. Check
    36 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T15:58:22.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    Core content status updated: results moved from
    Difference
    0.2%
    Check dated 2025-09-29T09:53:15.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2 and the Back to Top link was removed; no core content or time-sensitive information was altered.
    Difference
    0.2%
    Check dated 2025-09-15T00:14:46.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:31:22.000Z thumbnail image

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.